scispace - formally typeset
Patent

Protein-free culture medium

Reads0
Chats0
TLDR
A trace element mixture suitable for use in a protein-free tissue culture medium, which comprises water-soluble compounds selected from acids, bases, and salts containing copper, iron, zinc, manganese, silicon, molybdenum, vanadium, nickel, tin, aluminum, silver, barium, bromine, cadmium, cobalt, chromium, fluorine, germanium, iodine, rubidium, zirconium, or selenium, is described in this article.
Abstract
A trace element mixture suitable for use in a protein-free tissue culture medium, which comprises water-soluble compounds selected from acids, bases, and salts containing copper, iron, zinc, manganese, silicon, molybdenum, vanadium, nickel, tin, aluminum, silver, barium, bromine, cadmium, cobalt, chromium, fluorine, germanium, iodine, rubidium, zirconium, or selenium, the compounds being devoid of any additional metals other than those present as positive ions selected from groups IA and IIA of the periodic table of elements, wherein the compounds produce a solution containing specified minimum concentrations of the listed elements when dissolved in an amount of water sufficient to produce a concentration for one of the elements equal to the corresponding minimum concentration of the one element while maintaining each remaining element at a concentration equal to or greater than the minimum concentration for the remaining element is disclosed along with cell culture media containing these trace elements and methods of culturing cells using these media.

read more

Citations
More filters
Patent

Polypeptide variants with altered effector function

TL;DR: In this article, the present invention concerns polypeptides comprising a variant of the Fc region, which have altered effector function as a consequence of one or more amino acid modifications in the region thereof.
Patent

Multivalent antibodies and uses therefor

TL;DR: In this paper, the authors describe engineered antibodies with three or more functional antigen binding sites, and uses such as therapeutic applications for such engineered antibodies, such as drug discovery and drug development.
Patent

Immunoglobulin variants and uses thereof

TL;DR: In this paper, humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases were provided for the treatment of cancer and other diseases.
Patent

Anti-VEGF antibodies

TL;DR: In this article, humanized and variant anti-VEGF antibodies and various uses therefor are disclosed, which have strong binding affinities for VEGF; inhibit VEGFs-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo.
Patent

Anti-pd-l1 antibodies and their use to enhance t-cell function

TL;DR: In this paper, anti-PD-L1 antibodies are used to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity.
References
More filters
Journal ArticleDOI

Production of monoclonal antibodies in serum free medium

TL;DR: Several established hybridoma cell lines are grown in a serum free medium supplemented with physiological concentrations of insulin and transferrin and will secrete monoclonal antibodies in quantities comparable to those produced in the presence of serum.
Journal Article

Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium.

TL;DR: A serum-free medium formulation that allows a primary in vitro antibody response to the nonmitogenic thymic independent antigen TNP-AECM-Ficoll is described and should prove useful in defining the molecular requirements for B lymphocyte activation by antigen.
Book

Plant cell and tissue culture

TL;DR: By reading plant cell and tissue culture, you can take more advantages with limited budget.